Approval of and access to delamanid is crucial while further research is pending.

The Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a negative opinion for delamanid for the treatment of pulmonary multidrug-resistant tuberculosis in combination with an optimised background regimen according to WHO guidelines in patients.

FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin.

NIH-funded study suggests test may increase treatment in primary care settings.

With the President’s Emergency Plan for AIDS Relief  facing a drop from fiscal year 2012 funding, the House Appropriations Committee added language from Rep. Barbara Lee to the funding bill it voted on today, requiring indicators to ensure that “country ownership” is pursued effectively and appropriately.

Yale researchers have identified a common genetic variant that makes people infected with HIV much more susceptible to tuberculosis (TB). The study is published in the online Early Edition of the Proceedings of the National Academy of Sciences.

Today the Senate Subcommittee on State and Foreign Operations followed the House’s example by adopting the President’s fiscal year 2014 funding request for global HIV/AIDS programs, allocating $4.02 billion for the President’s Emergency Plan for AIDS Relief and $1.65 billion for the Global Fund to Fight AIDS, TB, and Malaria.  The bill also provides $330 million for USAID’s HIV/AIDS programs, in line with the President’s request.

Re: Further research into sutezolid urgently needed for tuberculosis

Abstract

SRINAGAR, India, Jul 22 (IPS) - Twenty-three-year-old Haleema (not her real name) was not the first female patient at Srinagar's Chest Diseases Hospital in the Indian state of Kashmir to try to run away.